Betaine Protects Chronic Alcohol and ω‐3 PUFA‐Mediated Down‐Regulations of PON1 Gene, Serum PON1 and Homocysteine Thiolactonase Activities With Restoration of Liver GSH
Authors:
- 2 March 2010
- journal article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 34 (3) , 424-431
Abstract
Paraoxonase (PON1) is an antioxidant enzyme that prevents LDL oxidation as well as detoxifies homocysteine thiolactone (HCTL), both of which can cause atherosclerosis. Chronic alcohol (ETOH) and high omega-3 polyunsaturated fatty acids (omega-3 PUFA) consumption may affect PON1 status presumably via reactive oxygen species by depleting liver glutathione (GSH), whereas betaine may counter their effects. Therefore, we investigated the influence of ETOH, omega-3 PUFA, and betaine on liver GSH, PON1 expression, lipid score, as well as serum PON1 and HCTLase activities. Experimental rats belonging to various dietary groups were pair-fed with Lieber-DeCarli low (2.8% the dietary calories as omega3-fatty acids) and high (13.8% the dietary calories as omega3-fatty acids) menhaden fish alcohol-liquid diets with and without betaine (10 g/l diet) for 8 weeks after which liver PON1 mRNA, GSH, lipid score, and serum PON1, HCTLase, and ALT activities were measured. High omega-3 PUFA decreased liver PON1 mRNA expression, serum PON1, and HCTLase activity by 23% (p < 0.01), 20% (p < 0.05), and 28% (p < 0.05), respectively compared to the low omega-3 PUFA group. ETOH decreased PON1 mRNA expression by 25 and 30% (p < 0.01) with concomitant 27% (p < 0.05) and 38% (p < 0.01), decrease in liver GSH levels in low and high omega-3 PUFA groups, respectively. Correspondingly, serum PON1 activity decreased by 23% (p < 0.05) and 58% (p < 0.01) while serum HCTLase activity decreased by 25% (p < 0.05) and 59% (p < 0.01) in the low and high omega-3 PUFA ETOH groups, respectively. Betaine restored liver PON1 mRNA expressions in low and high omega-3 PUFA ETOH groups with parallel restorations of PON1 activity and liver GSH. Concomitantly, betaine reduced hepatosteatosis accompanied by alleviation of liver injury caused by chronic alcohol and high omega-3 PUFA. Based on these results, we conclude that dietary betaine not only atheroprotective by restoring liver GSH that quenches free radicals, but also may alleviate liver injury by reducing hepatosteatosis.Keywords
This publication has 34 references indexed in Scilit:
- S‐Adenosylmethionine Attenuates Hepatic Lipid Synthesis in Micropigs Fed Ethanol With a Folate‐Deficient DietAlcohol, Clinical and Experimental Research, 2007
- Paraoxonase-2 Reduces Oxidative Stress in Vascular Cells and Decreases Endoplasmic Reticulum Stress–Induced Caspase ActivationCirculation, 2007
- The molecular basis of homocysteine thiolactone-mediated vascular diseaseClinical Chemistry and Laboratory Medicine (CCLM), 2007
- Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assayClinica Chimica Acta, 2005
- The effect of taurine or betaine pretreatment on hepatotoxicity and prooxidant status induced by lipopolysaccharide treatment in the liver of ratsEuropean Journal of Gastroenterology & Hepatology, 2005
- Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Kinetics of HDL Cholesterol and Paraoxonase Activity in Moderate Alcohol ConsumersAlcohol, Clinical and Experimental Research, 2002
- Effect of Chronic Alcohol Consumption on Total Plasma Homocysteine Level in RatsAlcohol, Clinical and Experimental Research, 2000
- Changes in Cytochromes P‐450, 2E1, 2B1, and 4A, and Phospholipases A and C in the Intragastric Feeding Rat Model for Alcoholic Liver Disease: Relationship to Dietary Fats and Pathologic Liver InjuryAlcohol, Clinical and Experimental Research, 1994
- Dietary factors and Alcoholic CirrhosisAlcohol, Clinical and Experimental Research, 1986